Eisaku Nakamura
Director/Board Member at KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Eisaku Nakamura active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 29/02/2016 | - |
| Independent Dir/Board Member | 29/02/2016 | - | |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Director/Board Member | 28/03/2018 | - |
| Independent Dir/Board Member | 28/03/2018 | - | |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 31/12/2016 | - |
| Director/Board Member | 31/08/2013 | 31/12/2016 |
Career history of Eisaku Nakamura
Former positions of Eisaku Nakamura
| Companies | Position | Start | End |
|---|---|---|---|
| ACUCELA INC | Director/Board Member | 30/04/2015 | - |
Statistics
International
| Japan | 4 |
| United States | 2 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
- Stock Market
- Insiders
- Eisaku Nakamura
- Experience
